Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

CCR5 Genotype May Confer Resistance to Vertical HIV-1




 

Reuters Health Information Services (07/26/99)

Investigators believe that children who inherit the homozygous delta 32 CCR5 genotype may be protected from vertical HIV-1 infection. The homozygous delta 32 CCR5 genotype has been observed to confer resistance in adults. Dr. Sean Philpott, of the New York State Department of Health in Albany, and colleagues, investigated by determining the CCR5 genotype in 552 infants born to women infected with HIV-1. The researchers, who reported their findings in the July 1st issue of the Journal of Acquired Immune Deficiency Syndromes, suggest that the delta 32 homozygous genotype may provide resistance against both sexual and parental transmission of HIV-1.



 


Copyright © 1999 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in July 27, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.